Harmony TPV Post-Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 174 participants.

Also called NCT05077774

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 174 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05077774
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05077774. Allocation not applicable; no masking; primary purpose treatment. Start 2021-10-25 (actual); primary completion 2026-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Harmony TPV Post-Approval Study
Condition
Congenital Heart Disease
Condition
Tetrology of Fallot
Condition
RVOT Anomaly
Condition
Pulmonary Regurgitation
Intervention (Device)
Harmony TPV System
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct05077774
Content hash
e66f4b94e0a4fc47c516de5cc21aea0d53edec5efc84e57e0997fdb3e4cf618e